DiaSys (DYXC) Stock Price, News & Analysis

Company Overview

DiaSys Diagnostic Systems GmbH, trading as OTCMKTS:DYXC, is a global developer, manufacturer and distributor of in vitro diagnostic reagents and systems. The company specializes in clinical chemistry and point-of-care testing solutions, providing a comprehensive portfolio of reagents for routine clinical parameters, specialty protein assays and electrolytes. It also supplies calibration and quality control materials designed to ensure the accuracy and reliability of laboratory results.

DiaSys offers a broad range of diagnostic products, including ready-to-use reagent kits, lyophilized reagents and automated test panels compatible with a variety of bench-top and high-throughput analyzers. The company supports clinical laboratories, hospitals and point-of-care settings with technical services, instrument support and customized assay development. Its product lineup encompasses assays for cardiology markers, diabetes management, therapeutic drug monitoring and general chemistry analyses.

Headquartered in Holzheim, Germany, DiaSys serves a global customer base through direct subsidiaries and distributor partnerships across Europe, the Middle East, Africa, Asia and Latin America. With a strong emphasis on research and development, the company focuses on advancing diagnostic capabilities by introducing innovative assay formats and expanding its reagent portfolio. DiaSys’s management team brings extensive experience in clinical diagnostics and life-science industries, guiding strategic growth in both emerging markets and established territories.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DYXC Stock Analysis - Frequently Asked Questions

How do I buy shares of DiaSys?

Shares of DYXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/06/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:DYXC
• CIK: N/A
• Web: www.diasys.com
• Phone: (203) 755-5083
• Fax: 203-755-5105
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A